GynecologyNews.net

Gynecology Xagena

Xagena Mappa
Medical Meeting
Onco News
Farmaexplorer.it

HER2 targeted therapies have substantially improved the prognosis of patients with breast cancer however they can be associated with cardiac toxicity. SAFE-HEaRt is the first investigator-initiated ...


Triple-negative breast cancer ( TNBC ) is an aggressive subtype of breast cancer, often resistant to standard of care therapies. An induced synthetic lethal interaction with combined EGFR ( epiderma ...


Two case-control studies have examined the associations between fruit and vegetable intake and endometriosis risk with contrasting results. Diets rich in fruits and vegetables include higher levels ...


The long-term effects of Metformin in women with polycystic ovarian syndrome ( PCOS ) are inadequately studied. The effects of Metformin on women with PCOS over 24-month with respect to menses, hor ...


The role of normal tissue gene promoter methylation in cancer risk is poorly understood. A study has evaluated associations between normal tissue BRCA1 methylation and ovarian cancer risk. Researc ...


In 2011, the FDA ( Food and Drug Administration ) identified a possible association between breast implants and the development of anaplastic large cell lymphoma ( ALCL ), a rare type of non-Hodgkin's ...


New research has shown that women over 50 who have been treated for ductal carcinoma in situ ( DCIS ) are more likely to be alive ten years later than women in the general population. DCIS differs ...


Although there are various hormone therapies, including gonadotropin-releasing hormone agonist, Danazol, Levonorgestrel-releasing intrauterine system, Dienogest, and low-dose estrogen progestin, no co ...


The aim of a study was to evaluate the cumulative recurrence rates of ovarian endometrioma among patients using a Levonorgestrel-releasing intrauterine system ( LNG-IUS ) after conservative laparoscop ...


Previous data on inflammatory bowel disease ( IBD ) relapse during pregnancy mainly originate from retrospective studies. The aim of this study was (i) to evaluate the effect of active disease at conc ...


Palbociclib ( Ibrance ) is an oral small-molecule inhibitor of cyclin-dependent kinases 4 and 6. In the randomized, open-label, phase II PALOMA-1/TRIO-18 trial, Palbociclib in combination with Letrozo ...


Researchers have assessed scores for sexual dysfunction risk and quality of life in a cohort of women in Brazil who had a history of sexual abuse. The present study was a secondary analysis of a cr ...


The aim of a study was to characterize the maternal glycemic response to Betamethasone in subjects without diabetes compared to subjects with diabetes. Blood glucose levels in 22 gravidae without d ...


A study has estimated the prevalence of surgically confirmed endometriosis in women undergoing laparoscopic or abdominal hysterectomy, including those with and without preoperative indications of chro ...


Results from the second of two replicate pivotal phase 3 clinical trials evaluating the efficacy and safety of Elagolix in premenopausal women who suffer pain from endometriosis were presented. Tria ...